Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

trial · primary record

Brenipatide

Depressive Disorder, Major

PhasePhase 3
StatusRECRUITING
SponsorUnknown
Enrolment1000
Primary completion2029-02
Primary endpointTime to Relapse Defined as the Number of Days from Randomization to Date on Which the Participant Meets Any Relapse Criterion of Major Depressive Disorder (MDD)
Registry IDNCT07775300

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-11-04T03:54:43.967Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07775300

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.